Celldex Therapeutics | CLDX - Pre Tax Profit

Stock Price
33.83
Daily Change
0.50 1.50%
Monthly
12.06%
Yearly
90.06%
Q2 Forecast
31.36

Celldex Therapeutics reported $-81.32M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Agenus USD -10.61M 263.52M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Roche Holding CHF 4.79B 3.01B Jun/2025